FFO
CRL icon

Fortitude Family Office’s Charles River Laboratories CRL Stock Holding History

Fortitude Family Office’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58K Buy
29
+6
+26% +$1.07K ﹤0.01% 953
2026
Q1 		$3.97K Buy
23
+12
+109% +$2.23K ﹤0.01% 1008
2025
Q4 		$2.19K Buy
11
+1
+10% +$181 ﹤0.01% 1138
2025
Q3 		$1.56K Buy
10
+2
+25% +$318 ﹤0.01% 1362
2025
Q2 		$1.21K Sell
8
-1
-11% -$133 ﹤0.01% 1419
2025
Q1 		$1.35K Sell
9
-10
-53% -$1.68K ﹤0.01% 979
2024
Q4 		$3.51K Hold
19
– – ﹤0.01% 928
2024
Q3 		$3.74K Buy
+19
New +$3.95K ﹤0.01% 874

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Fortitude Family Office's CRL Position: Q2 2026 in Review

Fortitude Family Office increased its Charles River Laboratories (CRL) stake by 26% in Q2 2026, buying an estimated $1.07K and bringing the position to 29 shares worth $6.58K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Fortitude Family Office first reported a position in CRL in Q3 2024 and has held it in 8 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Fortitude Family Office held 29 shares of Charles River Laboratories worth $6.58K as of Q2 2026.
  • Fortitude Family Office bought 6 Charles River Laboratories shares in Q2 2026, an estimated $1.07K.
  • Charles River Laboratories made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #953 holding.
  • Fortitude Family Office first reported a position in Charles River Laboratories in Q3 2024 and has held it in 8 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.